Subscribe to Newsletter
Business & Profession Other

Aflibercept and the Evolution of CRVO Management

Articles:

A brief history of CRVO and the treatment options
Andrew Lotery, Honorary Consultant Ophthalmologist at the University Hospital Southampton and Professor of Ophthalmology at the University of Southampton.

Aflibercept:leveraging efficacy and the window of opportunity
Bora Eldem, Hacettepe University Hospital, Ankara, Turkey.

Beyond clinical trials: the proactive treatand- extend approach
Anat Loewenstein, Tel Aviv Medical Center & Sackler Faculty of Medicine, University of Tel Aviv, Israel.

Treat-and-extend in the clinic: case study review
Stephan Michels, City Hospital Triemli, Zurich, Switzerland.

 

Download the pdf here

 

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.